| Matthew Vanover, OD | |
|
279 N Eastgate Ave, Springfield, MO 65802 | |
| (417) 512-8954 | |
| (417) 512-8855 |
| Full Name | Matthew Vanover |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 24 Years |
| Location | 279 N Eastgate Ave, Springfield, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114082633 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 2002030098 (Missouri) | Primary |
| Provider Name | Vanover Vision Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1750952941 PECOS PAC ID: 5193128312 Enrollment ID: O20210726003750 |
News Archive
Sphere Medical, innovator in critical care monitoring and diagnostics equipment, has published online a video of an industry seminar on ‘True Point-of-Care Testing' presented by Dr. Tom Clutton-Brock, Senior Lecturer Anaesthesia and Intensive Care Medicine, University Hospital Birmingham at the AAGBI 2014 Annual Congress.
Genzyme Corporation announced today that the two-year follow-up results from the phase 2 clinical trial of its investigational therapy known as eliglustat tartrate have been accepted for publication in the journal Blood. The results have been pre-published on the journal's website and are available to subscribers.
The New York Times reports that a possible agreement between President Barack Obama and congressional Republicans on "broad systemic changes to Medicare" could help spur a budget deal. And The Wall Street Journal reports the White House is weighing inclusion of some entitlement changes in its 2014 budget proposal as a way to prod further talks.
UCB, a leading biopharmaceutical company at the forefront of immunology treatment and research, is proud to sponsor several key sets of Cimzia (certolizumab pegol) data at the American College of Rheumatology's 2011 Annual Scientific Meeting in Chicago, November 5-9.
While refining ways to grow arterial endothelial cells in the lab, a regenerative biology team at the Morgridge Institute for Research at the University of Wisconsin-Madison unexpectedly unearthed a powerful new model for studying a hallmark of vascular disease.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Vanover, OD 1515 S Forrest Heights Ave, Springfield, MO 65809-2318 Ph: (417) 693-9512 | Matthew Vanover, OD 279 N Eastgate Ave, Springfield, MO 65802 Ph: (417) 512-8954 |
News Archive
Sphere Medical, innovator in critical care monitoring and diagnostics equipment, has published online a video of an industry seminar on ‘True Point-of-Care Testing' presented by Dr. Tom Clutton-Brock, Senior Lecturer Anaesthesia and Intensive Care Medicine, University Hospital Birmingham at the AAGBI 2014 Annual Congress.
Genzyme Corporation announced today that the two-year follow-up results from the phase 2 clinical trial of its investigational therapy known as eliglustat tartrate have been accepted for publication in the journal Blood. The results have been pre-published on the journal's website and are available to subscribers.
The New York Times reports that a possible agreement between President Barack Obama and congressional Republicans on "broad systemic changes to Medicare" could help spur a budget deal. And The Wall Street Journal reports the White House is weighing inclusion of some entitlement changes in its 2014 budget proposal as a way to prod further talks.
UCB, a leading biopharmaceutical company at the forefront of immunology treatment and research, is proud to sponsor several key sets of Cimzia (certolizumab pegol) data at the American College of Rheumatology's 2011 Annual Scientific Meeting in Chicago, November 5-9.
While refining ways to grow arterial endothelial cells in the lab, a regenerative biology team at the Morgridge Institute for Research at the University of Wisconsin-Madison unexpectedly unearthed a powerful new model for studying a hallmark of vascular disease.
› Verified 8 days ago
Vision Rehabilitation Center Of The Ozarks Optometrist Medicare: Medicare Enrolled Practice Location: 1661 West Elfindale, Springfield, MO 65807 Phone: 417-831-0555 Fax: 417-831-0532 | |
Eli B Lemonier, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1724 W Kearney St Ste 116, Springfield, MO 65803 Phone: 417-865-4448 Fax: 417-862-8704 | |
Dr. Anita Baldwin, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 319 E Battlefield Rd, Suite Q, Springfield, MO 65807 Phone: 417-889-0500 Fax: 417-889-8407 | |
Dr. Jon Eugene Treadway, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 640 W Chestnut St, Springfield, MO 65806 Phone: 417-869-3937 Fax: 417-869-0281 | |
Pierce Vision Specialists Optometrist Medicare: Medicare Enrolled Practice Location: 3626 South Ave, Springfield, MO 65807 Phone: 417-887-7151 Fax: 417-887-7153 | |
Dr. Matthew Blair Mccoy, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1229 E Seminole St Ste 430, Springfield, MO 65804 Phone: 417-820-9393 | |
Dr. Mitzi Herndon Lewis, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3440 S National Ave, Springfield, MO 65807 Phone: 417-886-5444 Fax: 417-886-6444 |